ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,432Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 939

$1.25M Total Retail Price of All Prescriptions

Rank: 22 out of 939

1,011 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 1,011 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

26% of this provider’s 1,011 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 20,327 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 1,302 796 S3 1 1
OMEPRAZOLE 1,056 843 2 5
LEVOTHYROXINE SODIUM 1,048 917 3 4
POTASSIUM CHLORIDE 871 721 4 9
LISINOPRIL 831 594 5 3
FUROSEMIDE 776 629 6 7
AMLODIPINE BESYLATE 742 646 7 6
METFORMIN HCL 643 463 8 8
SIMVASTATIN 562 410 9 2
GABAPENTIN 534 382 10 11
CITALOPRAM HBR 507 341 11 15
WARFARIN SODIUM 425 376 12 17
DONEPEZIL HCL 398 398 13 30
PRAVASTATIN SODIUM 394 308 14 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 388 283 15 23
MELOXICAM 372 317 16 14
NAMENDA 350 349 17 49
METOPROLOL TARTRATE 323 282 18 10
HYDROCHLOROTHIAZIDE 314 251 19 12
NEXIUM 286 126 20 18
MIRTAZAPINE 285 265 21 56
TAMSULOSIN HCL 277 227 22 27
ZOLPIDEM TARTRATE 268 166 23 20
CYCLOBENZAPRINE HCL 258 101 R 24 36
ALLOPURINOL 241 198 25 31
TRAZODONE HCL 236 170 26 26
CARVEDILOL 231 207 27 25
METOPROLOL SUCCINATE 220 183 28 21
LANTUS 212 106 29 59
GLIPIZIDE 212 128 29 52
CLOPIDOGREL 210 185 31 28
AZITHROMYCIN 210 166 31 32
TRAMADOL HCL 206 162 33 16
FLUTICASONE PROPIONATE 188 133 34 43
RANITIDINE HCL 187 149 35 35
PROMETHAZINE HCL 181 94 R 36 68
PROAIR HFA 170 62 37 41
LOSARTAN-HYDROCHLOROTHIAZIDE 167 129 38 55
QUETIAPINE FUMARATE 162 142 39 69
ADVAIR DISKUS 161 112 40 60
TRIAMTERENE-HCTZ 160 126 41 33
OXYCODONE HCL-ACETAMINOPHEN 154 60 S2 42 107
GLIPIZIDE XL 150 128 43 147
ATENOLOL 149 102 44 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 148 114 45 64
POLYETHYLENE GLYCOL 3350 145 131 46 57
ALENDRONATE SODIUM 145 137 46 40
SERTRALINE HCL 144 121 48 24
ATORVASTATIN CALCIUM 143 105 49 22
DIVALPROEX SODIUM 142 124 50 95
PREDNISONE 139 92 51 42
SEROQUEL XR 137 124 52 230
LOSARTAN POTASSIUM 136 131 53 29
VERAPAMIL ER 128 110 54 85
FAMOTIDINE 126 107 55 62
AMIODARONE HCL 126 113 55 160
PLAVIX 124 110 57 48
VENTOLIN HFA 124 66 57 80
SPIRONOLACTONE 119 93 59 71
GEMFIBROZIL 119 91 59 100
CYMBALTA 115 65 61 44
DIGOXIN 114 104 62 45
ISOSORBIDE MONONITRATE ER 112 102 63 53
AMITRIPTYLINE HCL 109 50 R 64 38
TRICOR 109 98 64 143
CRESTOR 108 97 66 34
LEVOFLOXACIN 105 84 67 86
CIPROFLOXACIN HCL 104 90 68 54
CARBIDOPA-LEVODOPA 103 99 69 102
MEGESTROL ACETATE 96 96 R 70 136
TIZANIDINE HCL 96 34 70 81
FLUOXETINE HCL 96 68 70 47
BUMETANIDE 95 70 73 124
DIOVAN 94 84 74 50
SUCRALFATE 87 71 75 96
PROPRANOLOL HCL 85 55 76 117
COMBIVENT 78 43 77 120
CLONIDINE HCL 78 35 77 39
CEPHALEXIN 77 62 79 77
ESTRADIOL 75 25 R 80 79
CELEBREX 75 44 80 106
FENTANYL 73 47 S2 82 104
BENAZEPRIL HCL 73 44 82 87
LYRICA 73 26 82 63
SEROQUEL 72 61 85 139
OXYCODONE HCL 70 0 S2 86 67
SINGULAIR 69 44 87 101
RAMIPRIL 68 56 88 91
GLIPIZIDE ER 66 55 89 88
VENLAFAXINE HCL 66 48 89 159
TERAZOSIN HCL 66 44 89 114
METOCLOPRAMIDE HCL 65 63 92 119
NYSTATIN 64 55 93 174
ESCITALOPRAM OXALATE 64 60 93 61
PHENYTOIN SODIUM EXTENDED 64 42 93 99
METHADONE HCL 63 13 S2 96 109
METHOTREXATE 62 35 97 240
PANTOPRAZOLE SODIUM 62 33 97 66
FENOFIBRATE 61 30 99 83
LOVASTATIN 59 38 100 46
METHOCARBAMOL 59 37 R 100 149
LANTUS SOLOSTAR 58 26 102 128
PREMARIN 58 37 R 102 111
SYMBICORT 57 33 104 137
ROPINIROLE HCL 56 31 105 78
OXYCODONE-ACETAMINOPHEN 56 29 S2 105 138
HYDROCODONE BIT-IBUPROFEN 55 0 S3 107 244
FLUCONAZOLE 55 34 107 140
SPIRIVA 55 32 107 73
BISOPROLOL FUMARATE 54 54 110 258
DILTIAZEM ER 54 47 110 94
NITROFURANTOIN 54 44 110 279
PAROXETINE HCL 53 22 113 70
DIOVAN HCT 51 48 114 74
GLIMEPIRIDE 50 33 115 37
DETROL LA 50 40 115 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 18, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.